Table 3: Ratios based on AJCC staging of malignant cases.
CRC cases |
Stage I/II |
Stage III/IV |
p-value |
t-value |
No lymph node metastasis |
Lymph node metastasis present |
p-value |
t-value |
NLR |
3.809 ± 2.803 |
3.717 ± 1.952 |
0.43 |
0.1 |
3.539 ± 1.866 |
3.680 ± 2.001 |
0.28 |
0.5 |
PLR |
251.38 ± 145.538 |
249.316 ± 110.958 |
0.47 |
0.07 |
285.058 ± 125.501 |
246.733 ± 114.175 |
0.35 |
0.3 |
PHR |
4.850 ± 4.024 |
4.136 ± 1.862 |
0.057 |
1.5 |
4.438 ± 2.301 |
4.102 ± 1.857 |
0.26 |
0.6 |
MPV/Pc |
0.0216 ± 0.0082 |
0.0246 ± 0.0101 |
0.07 |
1.5 |
0.0236 ± 0.0080 |
0.0248 ± 0.0102 |
0.07 |
1.5 |
MPV |
8.42 ± 1.26 |
9.22 ± 2.33 |
0.02 |
1.9 |
8.63 ± 1.28 |
9.22 ± 2.37 |
0.03 |
1.8 |